Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-26 4:23 pm Sale |
2021-01-26 | 13D | BridgeBio Pharma, Inc. BBIO |
Eidos Therapeutics Inc. EIDX |
0 0.000% |
-44,651,896 (Position Closed) |
Filing History |
| 2021-01-26 09:00 am Sale |
2021-01-26 | 13D | EIDOS THERAPEUTICS INC EIDX |
BridgeBio Pharma Inc. BBIO |
1,000 100.000% |
-24,574,501 (-100.00%) |
Filing History |
| 2020-10-15 4:17 pm Purchase |
2020-10-05 | 13D | BridgeBio Pharma, Inc. BBIO |
Eidos Therapeutics Inc. EIDX |
44,651,896 36.400% |
44,651,896 (New Position) |
Filing History |
| 2020-10-07 5:00 pm Sale |
2020-10-05 | 13D | EIDOS THERAPEUTICS INC EIDX |
RA Capital Management, L.P. | 1,798,339 4.700% |
-364,332 (-16.85%) |
Filing History |
| 2020-10-05 5:30 pm Unchanged |
2020-10-05 | 13D | EIDOS THERAPEUTICS INC EIDX |
BridgeBio Pharma Inc. BBIO |
24,575,501 63.700% |
0 (Unchanged) |
Filing History |